Organon & Co. (OGN) Soars to 52-Week High on $11.75-Billion Sun Merger

Organon & Co. (NYSE:OGN) is one of the 10 Stocks Racking Up Monster Gains. Organon soared to a new 52-week high on Monday, as investors gobbled up shares after the company officially confirmed its planned $11.

Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal

Organon (OGN +16.87%), a women’s health therapies specialist, closed Monday at $13.16, up 16.87%. The stock is jumping after premarket news that Sun Pharmaceutical Industries ag

Organon rides the pharma M&A wave with Sun takeover. The stock sizzles.

India’s Sun Pharmaceutical Industries agrees to buy the women’s health company for $14 a share in an all-cash deal.

Organon: What The Buyout Rumors Mean For The Stock

Organon (OGN) jumps on takeover rumors. Learn buyout odds, fair value, and downside risk if M&A fails amid weak revenue and high debt—read now.

Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition

With the purchase of Organon & Co., billionaire Dilip Shanghvi's Sun Pharmaceutical Industries' annual revenue will more than double to $12.4 billion and make it one of the world’s top 25 drugmakers.

Organon (OGN) Takeover Bid Climbs to $13B, Shares Soar 30.9%

Organon & Co. (NYSE:OGN) is one of the 10 High-Flying Stocks With Double-Digit Returns. Organon bounced back by 30.93 percent on Friday to close at $11.26 apiece, as investors snapped up shares following news that Sun Pharmaceuticals is upsizing its takeover offer of the company to $13 billion.